Pages that link to "Q35588726"
Jump to navigation
Jump to search
The following pages link to Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease (Q35588726):
Displaying 7 items.
- A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation (Q36471247) (← links)
- Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease (Q37075998) (← links)
- Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. (Q38629966) (← links)
- Cutaneous manifestations of graft-versus-host disease: role of the dermatologist (Q38961868) (← links)
- Classification systems for chronic graft-versus-host disease. (Q39002161) (← links)
- Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment (Q39401817) (← links)
- [Progress of chronic graft-versus-host disease] (Q87291596) (← links)